10x Genomics (TXG) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

TXG 10x Genomics

Watchlist

12.315
+0.375+3.14%

Close Feb 14 16:00 ET

12.400
+0.085+0.69%

Post 20:01 ET

1.51BMarket Cap-8.10P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

10x Genomics Is Maintained at Overweight by Morgan Stanley
Dow JonesFeb 14 09:09 ET · Ratings
Morgan Stanley Maintains 10x Genomics(TXG.US) With Buy Rating, Cuts Target Price to $26
Moomoo NewsFeb 14 08:31 ET · Ratings
A Quick Look at Today's Ratings for 10x Genomics(TXG.US), With a Forecast Between $12 to $18
Moomoo NewsFeb 14 08:00 ET · Ratings
Barclays Maintains Overweight on 10x Genomics, Lowers Price Target to $15
BenzingaFeb 14 06:43 ET · Ratings
Morgan Stanley Trims Price Target on 10x Genomics to $26 From $28, Keeps Overweight Rating
MT NewswiresFeb 14 06:26 ET · Ratings
10X Genomics Faces Financial Risks Amid Challenges in Data Interpretation and Customer Support
TipRanksFeb 14 01:01 ET

Comments

kingwang123

Feb 13 08:30

$10x Genomics (TXG.US)$ wtf new record low everyday.

Analysts Notebook

Feb 13 05:50

Columns Interest in AI-Powered MedTech is on the Rise: Key Stocks to Watch

The attention of AI Medteck stocks are rapidly increasing.
Pelosi's new holdings have doubled $Tempus AI (TEM.US)$ value in just a few weeks, and $Firefly Neuroscience (AIFF.US)$'s inclusion in NVIDIA's Connect program has also caused its stock price to soar.
In addition, DeepSeek's rapid rise has boosted the AI application sector, particularly in medicine/healthcare. Cathie Wood believes medical AI is undervalued, with untapped pot...